Global Leprosy Treatment Market is estimated to be US$ 4.09 billion by 2030 with a CAGR of 4.50% during the forecast period


Posted February 24, 2022 by sidhantk

Global Leprosy Treatment Market, By Drug Class (Antibacterial, Leprostatics, Antitubercular, Others), By Route Of Administration (Oral, Injectable, Topical).

 
Global leprosy treatment market accounted for US$ 2.65 billion in 2020 and is estimated to be US$ 4.09 billion by 2030 and is anticipated to register a CAGR of 4.50%. Leprosy caused by a Mycobacterium leprae bacteria. Leprosy is principally a granulomatous disease & it affects the skin, upper respiratory tract mucosal surfaces, peripheral nerves and the eyes majorly. The symptoms of leprosy include reddish skin lesions, loss of sensation, and weakness of hands and muscles. It is likely to cause nerve damage so as to induce muscle numbness. It is a communicable disease that can propagated through contact with cough or phlegm of the affected person. Generally, it is prevalent in low-income countries & malnutrition as well as weak immune system are other significant risk factors of leprosy. Leprosy can be cured by the Multidrug Therapy (MDT) which includes mixture of drugs like rifampicin, clofazimine and dapsone.

The report " Global Leprosy Treatment Market, By Drug Class (Antibacterial, Leprostatics, Antitubercular, Others), By Route Of Administration (Oral, Injectable, Topical), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, And Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Trends, Analysis, and Forecast till 2029’’
Key Highlights:

The United States Food and Medicine Administration has approved Novartis International AG's 'Egaten,' a drug used to treat fascioliasis and tropical diseases such as leprosy.
The Novartis Foundation, a non-profit organisation that is part of Novartis International AG, partnered with Microsoft in March 2019 to develop an artificial intelligence (AI)-enabled digital health application and a leprosy intelligent image atlas to help with early leprosy detection.
Analyst View:

Increasing rate of the prevalence of skin diseases increase the demand of Leprosy treatments. Also, government initiatives & favorable reimbursement are propelling factors for growth of the leprosy treatment market. Furthermore, findings of novel therapies also has positive impact on this market. Key companies in the market are focused on various business strategies such as partnership and collaboration & gaining product approvals, in order to provide better solution for leprosy treatment. Additionally, With the help of the Global Leprosy Strategy 2021–2030 “Towards zero leprosy” which was developed through a broad consultative process with all major stakeholders will effect positively on this market in upcoming years.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Leprosy Treatment Market, By Drug Class (Antibacterial, Leprostatics, Antitubercular, Others), By Route Of Administration (Oral, Injectable, Topical), And Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, And Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) - Trends, Analysis, and Forecast till 2029”
To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Leprosy-Treatment-Market-4855

Key Market Insights from the report:

Global leprosy treatment market accounted for US$ 2.65 billion in 2020 and is estimated to be US$ 4.09 billion by 2030 and is anticipated to register a CAGR of 4.50%. The Global Leprosy Treatment Market is segmented based on drug class, route of administration, distribution channel and region.

Based on Drug Class, Global Leprosy Treatment Market is segmented into Antibacterial, Leprostatics, Antitubercular, Others.
Based on Route of Administration, Global Leprosy Treatment Market is segmented into Oral, Injectable, Topical.
Based on Distribution Channel, Global Leprosy Treatment Market is segmented into Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies.
By Region, the Global Leprosy Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Competitive Landscape & their strategies of Global Leprosy Treatment Market:

The key players operating in the leprosy treatment market includes the prominent player operating in the leprosy treatment market includes GlaxoSmithKline plc, Macleods Pharmaceuticals, Cadila Pharmaceuticals, Novartis AG, Systopic Laboratories Pvt. Ltd., AstraZeneca plc, Zydus Cadila, Merck & Co., Inc., Sanofi & HDT Biotech Corporation.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701

Email- [email protected]

Website- www.prophecymarketinsights.com
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By https://www.prophecymarketinsights.com/
Phone 8605312701
Business Address 964 E. Badillo Street #2042 Covina, CA 91724
Country United States
Categories Advertising , Marketing , Medical
Tags leprosy treatment market , leprosy treatment market keytrends , leprosy treatment market outlook , leprosy treatment market size
Last Updated February 24, 2022